1. Alfredsson, G., & Sedvall, G. (1976). Mass fragmentographic analysis of chlorpromazine in human plasma. In G. Sedvall, B. Uvnas, & Y. Zotterman (Eds.), Antipsychotic drugs: Pharmacokinetics. (pp. 367–372 ) Oxford: Pergamon Press.
2. Aman, M.G., & Singh, N.N. (1980). The usefulness of thioridazine for treating childhood disorders—fact or folklore? American Journal of Mental Deficiency, 84, 331–338.
3. Aman, M.G., & Singh, N.N. (1983). Pharmacological intervention. In J.L. Matson & J.A. Mulick (Eds.), Handbook of mental retardation. (pp. 317–337 ). Elmsford, NY: Pergamon.
4. Aman, M.G., Singh, N.N., Stewart, A.W., & Field, C.J. (1985a). The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.
5. Aman, M.G., Singh, N.N., Stewart, A.W., & Field, C.J. (1985b). Psychometric characteristics of the Aberrant Behavior Checklist. American Journal of Mental Deficiency, 89, 492–502.